DXR - Daxor Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201112/31/201012/31/2009
Total Revenue1,446.3451,579.2571,688.826
Cost of Revenue652.511727.65704.866
Gross Profit793.834851.607983.96
Operating Expenses
Research Development2,705.9523,041.642,825.151
Selling General and Administrative3,874.2963,469.0783,267.997
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-5,786.414-5,659.111-5,109.188
Income from Continuing Operations
Total Other Income/Expenses Net-6,372.37814,070.94312,261.06
Earnings Before Interest and Taxes-12,327.7158,350.1567,151.872
Interest Expense---
Income Before Tax-12,327.7158,350.1567,151.872
Income Tax Expense-5,142.0763,381.8921,329.114
Minority Interest---
Net Income From Continuing Ops-7,185.6394,968.2645,822.758
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,185.6394,968.2645,822.758
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,185.6394,968.2645,822.758